tradingkey.logo

Utah Medical Products Inc

UTMD
55.930USD
+0.710+1.29%
終値 11/25, 16:00ET15分遅れの株価
179.20M時価総額
15.42直近12ヶ月PER

Utah Medical Products Inc

55.930
+0.710+1.29%

詳細情報 Utah Medical Products Inc 企業名

Utah Medical Products, Inc. is engaged in the business of producing medical services. The Company markets a range of medical devices used in critical care areas, especially the neonatal intensive care unit (NICU), the labor and delivery (L&D) department and the women's health center in hospitals, as well as medical devices sold to outpatient clinics and physician's offices. Its products include BT-CATH, CVX-RIPE, AROM-COT, MUC-X, CORDGUARD, DISPOSA-HOOD, DELTRAN PLUS, GESCO, PICC-NATE, LETZ System, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, LUMIN, and BioPharm HP-PRT, among others. BT-CATH is a uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device used immediately after birth to clear neonatal respiratory passages and reduce exposure to potential infections. AROM-CO is a finger cover with a prong designed to rupture maternal membranes with less patient pain and anxiety.

Utah Medical Products Incの企業情報

企業コードUTMD
会社名Utah Medical Products Inc
上場日Dec 01, 1982
最高経営責任者「CEO」Mr. Kevin L. Cornwell
従業員数155
証券種類Ordinary Share
決算期末Dec 01
本社所在地7043 S 300 West
都市MIDVALE
証券取引所NASDAQ Global Select Consolidated
United States of America
郵便番号84070
電話番号18015215301
ウェブサイトhttp://www.utahmed.com
企業コードUTMD
上場日Dec 01, 1982
最高経営責任者「CEO」Mr. Kevin L. Cornwell

Utah Medical Products Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Kevin L. Cornwell
Mr. Kevin L. Cornwell
Chairman of the Board, President, Chief Executive Officer, Secretary
Chairman of the Board, President, Chief Executive Officer, Secretary
188.47K
--
Mr. Paul O. Richins
Mr. Paul O. Richins
Independent Director
Independent Director
21.24K
-1.05%
Dr. James H. Beeson, M.D., Ph.D.
Dr. James H. Beeson, M.D., Ph.D.
Independent Director
Independent Director
13.13K
--
Mr. Ernst G. Hoyer
Mr. Ernst G. Hoyer
Lead Independent Director
Lead Independent Director
5.00K
--
Ms. Carrie Leigh
Ms. Carrie Leigh
Independent Director
Independent Director
51.00
--
Mr. Kevin Timken
Mr. Kevin Timken
Director
Director
--
--
Mr. Brian L. Koopman
Mr. Brian L. Koopman
Principal Financial Officer
Principal Financial Officer
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Kevin L. Cornwell
Mr. Kevin L. Cornwell
Chairman of the Board, President, Chief Executive Officer, Secretary
Chairman of the Board, President, Chief Executive Officer, Secretary
188.47K
--
Mr. Paul O. Richins
Mr. Paul O. Richins
Independent Director
Independent Director
21.24K
-1.05%
Dr. James H. Beeson, M.D., Ph.D.
Dr. James H. Beeson, M.D., Ph.D.
Independent Director
Independent Director
13.13K
--
Mr. Ernst G. Hoyer
Mr. Ernst G. Hoyer
Lead Independent Director
Lead Independent Director
5.00K
--
Ms. Carrie Leigh
Ms. Carrie Leigh
Independent Director
Independent Director
51.00
--
Mr. Kevin Timken
Mr. Kevin Timken
Director
Director
--
--

収益内訳

通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
事業別USD
会社名
収益
比率
Gynecology/Electrosurgery/Urology
4.81M
48.30%
Neonatal
2.10M
21.12%
Blood Pressure Monitoring and Accessories
2.02M
20.29%
Obstetrics
1.02M
10.30%
会社から関連データがまだ開示されていません。
事業別
地域別
事業別USD
会社名
収益
比率
Gynecology/Electrosurgery/Urology
4.81M
48.30%
Neonatal
2.10M
21.12%
Blood Pressure Monitoring and Accessories
2.02M
20.29%
Obstetrics
1.02M
10.30%

株主

更新時刻: Sun, Nov 16
更新時刻: Sun, Nov 16
株主統計
種類
株主統計
株主統計
比率
Brandes Investment Partners, L.P.
10.55%
Renaissance Technologies LLC
6.27%
Dimensional Fund Advisors, L.P.
6.24%
Cornwell (Kevin L)
5.88%
The Vanguard Group, Inc.
5.48%
他の
65.57%
株主統計
株主統計
比率
Brandes Investment Partners, L.P.
10.55%
Renaissance Technologies LLC
6.27%
Dimensional Fund Advisors, L.P.
6.24%
Cornwell (Kevin L)
5.88%
The Vanguard Group, Inc.
5.48%
他の
65.57%
種類
株主統計
比率
Investment Advisor
40.97%
Investment Advisor/Hedge Fund
19.39%
Hedge Fund
8.74%
Individual Investor
7.14%
Research Firm
0.70%
Bank and Trust
0.18%
Pension Fund
0.05%
Insurance Company
0.04%
他の
22.79%

機関投資家保有株

更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
243
2.27M
70.80%
-636.90K
2025Q2
249
2.53M
77.79%
-699.23K
2025Q1
251
2.54M
78.08%
-658.65K
2024Q4
245
2.63M
77.47%
-634.89K
2024Q3
233
2.73M
78.80%
-558.16K
2024Q2
224
2.74M
78.05%
-528.35K
2024Q1
214
2.81M
78.59%
-191.73K
2023Q4
203
2.83M
78.07%
-204.85K
2023Q3
194
2.97M
81.82%
-7.55K
2023Q2
183
2.95M
81.20%
-24.79K
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
Brandes Investment Partners, L.P.
333.20K
10.39%
+61.88K
+22.81%
Aug 31, 2025
Renaissance Technologies LLC
213.31K
6.65%
-4.40K
-2.02%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
197.47K
6.16%
+4.51K
+2.34%
Jun 30, 2025
Cornwell (Kevin L)
188.47K
5.88%
--
--
Mar 03, 2025
The Vanguard Group, Inc.
177.10K
5.52%
+730.00
+0.41%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
157.93K
4.93%
+12.53K
+8.61%
Jun 30, 2025
Hotchkis and Wiley Capital Management, LLC
111.95K
3.49%
+10.31K
+10.14%
Jun 30, 2025
Minerva Advisors LLC
93.06K
2.9%
+6.16K
+7.08%
Jun 30, 2025
Geode Capital Management, L.L.C.
114.82K
3.58%
+7.04K
+6.53%
Jun 30, 2025
State Street Investment Management (US)
70.12K
2.19%
-10.03K
-12.51%
Jun 30, 2025
詳細を見る

関連ETF

更新時刻: Thu, Nov 6
更新時刻: Thu, Nov 6
銘柄名
比率
Acquirers Small and Micro Deep Value ETF
1.03%
JPMorgan Fundamental Data Science Small Core ETF
0.23%
Royce Quant Small-Cap Quality Value ETF
0.23%
WisdomTree U.S. SmallCap Dividend Fund
0.06%
iShares Micro-Cap ETF
0.04%
Avantis US Small Cap Equity ETF
0.02%
Global X Russell 2000 ETF
0.01%
DFA Dimensional US Small Cap Value ETF
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
ProShares Hedge Replication ETF
0.01%
詳細を見る
Acquirers Small and Micro Deep Value ETF
比率1.03%
JPMorgan Fundamental Data Science Small Core ETF
比率0.23%
Royce Quant Small-Cap Quality Value ETF
比率0.23%
WisdomTree U.S. SmallCap Dividend Fund
比率0.06%
iShares Micro-Cap ETF
比率0.04%
Avantis US Small Cap Equity ETF
比率0.02%
Global X Russell 2000 ETF
比率0.01%
DFA Dimensional US Small Cap Value ETF
比率0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
比率0.01%
ProShares Hedge Replication ETF
比率0.01%

配当金

過去5年間の配当金総支払額は 27.29M 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
Feb 04, 2025
UTMD.NB Final Cash Dividend of gross USD 0.305 paid on Apr 03, 2025 going ex on Mar 14, 2025
Mar 14, 2025
Apr 03, 2025
Mar 14, 2025
Dec 11, 2024
UTMD.NB Interim Cash Dividend of gross USD 0.305 paid on Jan 03, 2025 going ex on Dec 16, 2024
Dec 16, 2024
Jan 03, 2025
Dec 16, 2024
Aug 02, 2024
UTMD.NB Interim Cash Dividend of gross USD 0.3 paid on Oct 04, 2024 going ex on Sep 20, 2024
Sep 20, 2024
Oct 04, 2024
Sep 20, 2024
May 07, 2024
UTMD.NB Interim Cash Dividend of gross USD 0.3 paid on Jul 05, 2024 going ex on Jun 14, 2024
Jun 14, 2024
Jul 05, 2024
Jun 14, 2024
Feb 06, 2024
UTMD.NB Final Cash Dividend of gross USD 0.3 paid on Apr 03, 2024 going ex on Mar 14, 2024
Mar 15, 2024
Apr 03, 2024
Mar 14, 2024
Oct 31, 2023
UTMD.NB Interim Cash Dividend of gross USD 0.3 paid on Jan 03, 2024 going ex on Dec 14, 2023
Dec 15, 2023
Jan 03, 2024
Dec 14, 2023
Aug 02, 2023
UTMD.NB Interim Cash Dividend of gross USD 0.295 paid on Oct 03, 2023 going ex on Sep 14, 2023
Sep 15, 2023
Oct 03, 2023
Sep 14, 2023
May 10, 2023
UTMD.NB Interim Cash Dividend of gross USD 0.295 paid on Jul 06, 2023 going ex on Jun 15, 2023
Jun 16, 2023
Jul 06, 2023
Jun 15, 2023
Feb 07, 2023
UTMD.NB Final Cash Dividend of gross USD 0.295 paid on Apr 04, 2023 going ex on Mar 16, 2023
Mar 17, 2023
Apr 04, 2023
Mar 16, 2023
Nov 02, 2022
UTMD.NB Interim Cash Dividend of gross USD 0.295 paid on Jan 04, 2023 going ex on Dec 15, 2022
Dec 16, 2022
Jan 04, 2023
Dec 15, 2022
詳細を見る

株式分割

日付
種類
比率
データなし
日付
種類
比率
データなし

よくある質問

Utah Medical Products Incの上位5名の株主は誰ですか?

Utah Medical Products Incの上位5名の株主は以下のとおりです。
Brandes Investment Partners, L.P.は333.20K株を保有しており、これは全体の10.39%に相当します。
Renaissance Technologies LLCは213.31K株を保有しており、これは全体の6.65%に相当します。
Dimensional Fund Advisors, L.P.は197.47K株を保有しており、これは全体の6.16%に相当します。
Cornwell (Kevin L)は188.47K株を保有しており、これは全体の5.88%に相当します。
The Vanguard Group, Inc.は177.10K株を保有しており、これは全体の5.52%に相当します。

Utah Medical Products Incの株主タイプ上位3種は何ですか?

Utah Medical Products Incの株主タイプ上位3種は、
Brandes Investment Partners, L.P.
Renaissance Technologies LLC
Dimensional Fund Advisors, L.P.

Utah Medical Products Inc(UTMD)の株式を保有している機関の数はいくつですか?

2025Q3時点で、Utah Medical Products Incの株式を保有している機関は243社あり、保有株式の総市場価値は約2.27Mで、全体の70.80%を占めています。2025Q2と比較して、機関の持ち株は-6.99%増加しています。

Utah Medical Products Incの最大の収益源は何ですか?

FY2025Q2において、Gynecology/Electrosurgery/Urology部門がUtah Medical Products Incにとって最大の収益を生み出しており、その金額は4.81Mで、全収益の48.30%を占めています。
KeyAI